{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T03:08:44Z","timestamp":1792292924964,"version":"4.4.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,7,3]],"date-time":"2009-07-03T00:00:00Z","timestamp":1246579200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1007\/s10875-009-9315-7","type":"journal-article","created":{"date-parts":[[2009,7,2]],"date-time":"2009-07-02T07:22:52Z","timestamp":1246519372000},"page":"769-776","source":"Crossref","is-referenced-by-count":49,"title":["Clinical and Laboratory Findings in Hyper-IgM Syndrome with Novel CD40L and AICDA Mutations"],"prefix":"10.1007","volume":"29","author":[{"given":"Asghar","family":"Aghamohammadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima","family":"Parvaneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasra","family":"Moazzami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Kashef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Abolhassani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Imanzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javad","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennart","family":"Hammarstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,7,3]]},"reference":[{"key":"9315_CR1","first-page":"101","volume":"3","author":"LD Notarangelo","year":"1992","unstructured":"Notarangelo LD, Duse M, Ugazio AG. Immunodeficiency with hyper-IgM (HIM). Immunodefic Rev. 1992;3:101\u201321.","journal-title":"Immunodefic Rev"},{"key":"9315_CR2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-3476(97)70123-9","volume":"131","author":"J Levy","year":"1997","unstructured":"Levy J, Espanol-Boren T, Thomas C, Fischer A, Tovo P, Bordigoni P, et al. Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr. 1997;131:47\u201354.","journal-title":"J Pediatr"},{"key":"9315_CR3","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/361539a0","volume":"361","author":"U Korthauer","year":"1993","unstructured":"Korthauer U, Graf D, Mages HW, Briere F, Padayachee M, Malcolm S, et al. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature. 1993;361:539\u201341.","journal-title":"Nature"},{"key":"9315_CR4","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0092-8674(93)90668-G","volume":"72","author":"A Aruffo","year":"1993","unstructured":"Aruffo A, Farrington M, Hollenbaugh D, Li X, Milatovich A, Nonoyama S, et al. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell. 1993;72:291\u2013300.","journal-title":"Cell"},{"key":"9315_CR5","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.4049\/jimmunol.158.6.2576","volume":"158","author":"A Durandy","year":"1997","unstructured":"Durandy A, Hivroz C, Mazerolles F, Schiff C, Bernard F, Jouanguy E, et al. Abnormal CD40-mediated activation pathway in B lymphocytes from patients with hyper-IgM syndrome and normal CD40 ligand expression. J Immunol. 1997;158:2576\u201384.","journal-title":"J Immunol"},{"key":"9315_CR6","doi-asserted-by":"crossref","first-page":"12614","DOI":"10.1073\/pnas.221456898","volume":"98","author":"S Ferrari","year":"2001","unstructured":"Ferrari S, Giliani S, Insalaco A, Al-Ghonaium A, Soresina AR, Loubser M, et al. Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM. Proc Natl Acad Sci U S A. 2001;98:12614\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9315_CR7","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0092-8674(00)00079-9","volume":"102","author":"P Revy","year":"2000","unstructured":"Revy P, Muto T, Levy Y, Geissmann F, Plebani A, Sanal O, et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell. 2000;102:565\u201375.","journal-title":"Cell"},{"key":"9315_CR8","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1172\/JCI18161","volume":"112","author":"K Imai","year":"2003","unstructured":"Imai K, Catalan N, Plebani A, Marodi L, Sanal O, Kumaki S, et al. Hyper-IgM syndrome type 4 with a B lymphocyte-intrinsic selective deficiency in Ig class-switch recombination. J Clin Invest. 2003;112:136\u201342.","journal-title":"J Clin Invest"},{"key":"9315_CR9","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1182\/blood-2003-12-4420","volume":"105","author":"WI Lee","year":"2005","unstructured":"Lee WI, Torgerson TR, Schumacher MJ, Yel L, Zhu Q, Ochs HD. Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome. Blood. 2005;105:1881\u201390.","journal-title":"Blood"},{"key":"9315_CR10","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jaci.2006.01.043","volume":"117","author":"LD Notarangelo","year":"2006","unstructured":"Notarangelo LD, Lanzi G, Peron S, Durandy A. Defects of class-switch recombination. J Allergy Clin Immunol. 2006;117:855\u201364.","journal-title":"J Allergy Clin Immunol"},{"key":"9315_CR11","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/ni974","volume":"4","author":"K Imai","year":"2003","unstructured":"Imai K, Slupphaug G, Lee WI, Revy P, Nonoyama S, Catalan N, et al. Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination. Nat Immunol. 2003;4:1023\u20138.","journal-title":"Nat Immunol"},{"key":"9315_CR12","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1084\/jem.20030481","volume":"197","author":"SK Dickerson","year":"2003","unstructured":"Dickerson SK, Market E, Besmer E, Papavasiliou FN. AID mediates hypermutation by deaminating single stranded DNA. J Exp Med. 2003;197:1291\u20136.","journal-title":"J Exp Med"},{"key":"9315_CR13","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/S0960-9822(02)01215-0","volume":"12","author":"C Rada","year":"2002","unstructured":"Rada C, Williams GT, Nilsen H, Barnes DE, Lindahl T, Neuberger MS. Immunoglobulin isotype switching is inhibited and somatic hypermutation perturbed in UNG-deficient mice. Curr Biol. 2002;12:1748\u201355.","journal-title":"Curr Biol"},{"key":"9315_CR14","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/01.bor.0000231905.12172.b5","volume":"18","author":"A Durandy","year":"2006","unstructured":"Durandy A, Peron S, Fischer A. Hyper-IgM syndromes. Curr Opin Rheumatol. 2006;18:369\u201376.","journal-title":"Curr Opin Rheumatol"},{"key":"9315_CR15","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1084\/jem.20080789","volume":"205","author":"S Peron","year":"2008","unstructured":"Peron S, Metin A, Gardes P, Alyanakian MA, Sheridan E, Kratz CP, et al. Human PMS2 deficiency is associated with impaired immunoglobulin class switch recombination. J Exp Med. 2008;205:2465\u201372.","journal-title":"J Exp Med"},{"key":"9315_CR16","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1182\/blood.V92.7.2421","volume":"92","author":"K Seyama","year":"1998","unstructured":"Seyama K, Nonoyama S, Gangsaas I, Hollenbaugh D, Pabst HF, Aruffo A, et al. Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome. Blood. 1998;92:2421\u201334.","journal-title":"Blood"},{"key":"9315_CR17","first-page":"233","volume":"19","author":"S Kashef","year":"2009","unstructured":"Kashef S, Ghaedian M, Rezaei N, Karamizadeh Z, Aghamohammadi A, Durandy A, et al. Isolated growth hormone deficiency in a patient with Immunoglobulin class switch recombination deficiency. J Investig Allergol Clin Immunol. 2009;19:233\u20136.","journal-title":"J Investig Allergol Clin Immunol"},{"key":"9315_CR18","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000142050","volume":"147","author":"N Rezaei","year":"2008","unstructured":"Rezaei N, Aghamohammadi A, Ramyar A, Pan-Hammarstrom Q, Hammarstrom L. Severe congenital neutropenia or hyper-IgM syndrome? A novel mutation of CD40 ligand in a patient with severe neutropenia. Int Arch Allergy Immunol. 2008;147:255\u20139.","journal-title":"Int Arch Allergy Immunol"},{"key":"9315_CR19","first-page":"37","volume":"6","author":"L Atarod","year":"2007","unstructured":"Atarod L, Aghamohammadi A, Moin M, Kanegane H, Rezaei N, Rezaei Kalantari K, et al. Successful management of neutropenia in a patient with CD40 ligand deficiency by immunoglobulin replacement therapy. Iran J Allergy Asthma Immunol. 2007;6:37\u201340.","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"9315_CR20","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1172\/JCI118389","volume":"97","author":"Q Lin","year":"1996","unstructured":"Lin Q, Rohrer J, Allen RC, Larche M, Greene JM, Shigeoka AO, et al. A single strand conformation polymorphism study of CD40 ligand. Efficient mutation analysis and carrier detection for X-linked hyper IgM syndrome. J Clin Invest. 1996;97:196\u2013201.","journal-title":"J Clin Invest"},{"key":"9315_CR21","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/01.md.0000100046.06009.b0","volume":"82","author":"JA Winkelstein","year":"2003","unstructured":"Winkelstein JA, Marino MC, Ochs H, Fuleihan R, Scholl PR, Geha R, et al. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine (Baltimore). 2003;82:373\u201384.","journal-title":"Medicine (Baltimore)"},{"key":"9315_CR22","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1046\/j.1365-2249.2000.01142.x","volume":"120","author":"LD Notarangelo","year":"2000","unstructured":"Notarangelo LD, Hayward AR. X-linked immunodeficiency with hyper-IgM (XHIM). Clin Exp Immunol. 2000;120:399\u2013405.","journal-title":"Clin Exp Immunol"},{"key":"9315_CR23","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1006\/clim.2000.4956","volume":"97","author":"Y Minegishi","year":"2000","unstructured":"Minegishi Y, Lavoie A, Cunningham-Rundles C, Bedard PM, Hebert J, Cote L, et al. Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome. Clin Immunol. 2000;97:203\u201310.","journal-title":"Clin Immunol"},{"key":"9315_CR24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.clim.2003.10.007","volume":"110","author":"P Quartier","year":"2004","unstructured":"Quartier P, Bustamante J, Sanal O, Plebani A, Debre M, Deville A, et al. Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to activation-induced cytidine deaminase deficiency. Clin Immunol. 2004;110:22\u20139.","journal-title":"Clin Immunol"},{"key":"9315_CR25","first-page":"41","volume":"50","author":"Y Zhu","year":"2003","unstructured":"Zhu Y, Nonoyama S, Morio T, Muramatsu M, Honjo T, Mizutani S. Type two hyper-IgM syndrome caused by mutation in activation-induced cytidine deaminase. J Med Dent Sci. 2003;50:41\u20136.","journal-title":"J Med Dent Sci"},{"key":"9315_CR26","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1136\/adc.74.5.458","volume":"74","author":"FJ Andrews","year":"1996","unstructured":"Andrews FJ, Katz F, Jones A, Smith S, Finn A. CD40 ligand deficiency presenting as unresponsive neutropenia. Arch Dis Child. 1996;74:458\u20139.","journal-title":"Arch Dis Child"},{"key":"9315_CR27","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/01.mph.0000172280.27318.80","volume":"27","author":"N Rezaei","year":"2005","unstructured":"Rezaei N, Farhoudi A, Ramyar A, Pourpak Z, Aghamohammadi A, Mohammadpour B, et al. Congenital neutropenia and primary immunodeficiency disorders: a survey of 26 Iranian patients. J Pediatr Hematol Oncol. 2005;27:351\u20136.","journal-title":"J Pediatr Hematol Oncol"},{"key":"9315_CR28","first-page":"77","volume":"3","author":"N Rezaei","year":"2004","unstructured":"Rezaei N, Farhoudi A, Pourpak Z, Aghamohammadi A, Moin M, Gharagozlou M, et al. Neutropenia in patients with primary antibody deficiency disorders. Iran J Allergy Asthma Immunol. 2004;3:77\u201381.","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"9315_CR29","first-page":"554","volume":"90","author":"N Rezaei","year":"2005","unstructured":"Rezaei N, Farhoudi A, Pourpak Z, Aghamohammadi A, Moin M, Movahedi M, et al. Neutropenia in Iranian patients with primary immunodeficiency disorders. Haematologica. 2005;90:554\u20136.","journal-title":"Haematologica"},{"key":"9315_CR30","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/00043426-200005000-00020","volume":"22","author":"M Mori","year":"2000","unstructured":"Mori M, Nonoyama S, Neubauer M, Mitsuda T, Kosuge K, Yokota S. Mutation analysis and therapeutic response to granulocyte colony-stimulating factor in a case of hyperimmunoglobulin M syndrome with chronic neutropenia. J Pediatr Hematol Oncol. 2000;22:288\u20139.","journal-title":"J Pediatr Hematol Oncol"},{"key":"9315_CR31","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/protein\/gzm004","volume":"20","author":"J Thusberg","year":"2007","unstructured":"Thusberg J, Vihinen M. The structural basis of hyper IgM deficiency\u2014CD40L mutations. Protein Eng Des Sel. 2007;20:133\u201341.","journal-title":"Protein Eng Des Sel"},{"key":"9315_CR32","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/85277","volume":"2","author":"A Jain","year":"2001","unstructured":"Jain A, Ma CA, Liu S, Brown M, Cohen J, Strober W. Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia. Nat Immunol. 2001;2:223\u20138.","journal-title":"Nat Immunol"},{"key":"9315_CR33","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1086\/501532","volume":"78","author":"A Puel","year":"2006","unstructured":"Puel A, Reichenbach J, Bustamante J, Ku CL, Feinberg J, Doffinger R, et al. The NEMO mutation creating the most-upstream premature stop codon is hypomorphic because of a reinitiation of translation. Am J Hum Genet. 2006;78:691\u2013701.","journal-title":"Am J Hum Genet"},{"key":"9315_CR34","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0065-2776(04)82007-8","volume":"82","author":"A Durandy","year":"2004","unstructured":"Durandy A, Revy P, Fischer A. Human models of inherited immunoglobulin class switch recombination and somatic hypermutation defects (hyper-IgM syndromes). Adv Immunol. 2004;82:295\u2013330.","journal-title":"Adv Immunol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-009-9315-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-009-9315-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-009-9315-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T23:59:28Z","timestamp":1710460768000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-009-9315-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,3]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["9315"],"URL":"https:\/\/doi.org\/10.1007\/s10875-009-9315-7","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,3]]}}}